Nuwellis, Inc.
NUWENASDAQHealthcare● Active
$0.15
$-0.02(-13.28%)
Market Cap$130886
P/E Ratio—
52W High$25.95
52W Low$0.13
Nuwellis, Inc. (NUWE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NUWE · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$2.09
Est. -$1.00 · -109.0%
Revenue
$0.00B
Est. $0.00B · +14.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
NUWE reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.68 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$1.00 | -$2.09 | -109.0% | $0.00B | $0.00B | +14.8% |
| ▲ Q1 FY2026 | Mar 10, 2026 | -$1.56 | -$1.50 | +3.9% | $0.00B | $0.00B | +4.9% |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$17.22 | $0.56 | +103.3% | $0.00B | $0.00B | -4.0% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$18.90 | -$60.99 | -222.7% | $0.00B | $0.00B | -21.6% |
| ▼ Q2 FY2025 | May 13, 2025 | -$18.91 | -$28.99 | -53.3% | $0.00B | $0.00B | -13.4% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -$0.43 | -$0.65 | -51.2% | $0.00B | $0.00B | -7.1% |
| ▲ Q4 FY2024 | Nov 11, 2024 | -$1.28 | $1.74 | +235.9% | $0.00B | $0.00B | -3.8% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.68
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$2.09
EPS Est.
-$1.00
EPS Surpr.
-109.0%
Revenue
$0.00B
Q1 FY2026
Mar 10, 2026Beat
EPS Actual
-$1.50
EPS Est.
-$1.56
EPS Surpr.
+3.9%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$0.56
EPS Est.
-$17.22
EPS Surpr.
+103.3%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$60.99
EPS Est.
-$18.90
EPS Surpr.
-222.7%
Revenue
$0.00B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$28.99
EPS Est.
-$18.91
EPS Surpr.
-53.3%
Revenue
$0.00B
Q1 FY2025
Mar 11, 2025Miss
EPS Actual
-$0.65
EPS Est.
-$0.43
EPS Surpr.
-51.2%
Revenue
$0.00B
Q4 FY2024
Nov 11, 2024Beat
EPS Actual
$1.74
EPS Est.
-$1.28
EPS Surpr.
+235.9%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.33 | $-0.33 | $-0.33 | 1 |
| Q3 FY2026 | $-0.39 | $-0.39 | $-0.39 | 1 |
| Q2 FY2026 | $-0.68 | $-0.68 | $-0.68 | 1 |
| Q1 FY2026 | $-1.00 | $-1.00 | $-1.00 | 1 |
| Q4 FY2025 | $-1.56 | $-1.56 | $-1.56 | 1 |
| Q3 FY2025 | $-17.22 | $-17.22 | $-17.22 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -109.0% | $1.04 | $1.03 | -0.96% |
| ▲ Q1 FY2026 | Mar 10, 2026 | +3.9% | $1.29 | $1.30 | +0.78% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +103.3% | $2.78 | $2.67 | -3.96% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -222.7% | $5.50 | $5.64 | +2.55% |
| ▼ Q2 FY2025 | May 13, 2025 | -53.3% | $41.58 | $41.96 | +0.91% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -51.2% | $52.92 | $50.82 | -3.97% |
| ▲ Q4 FY2024 | Nov 11, 2024 | +235.9% | $76.02 | $86.10 | +13.26% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -98.6% | $111.30 | $89.88 | -19.25% |
Q2 FY2026-0.96%
Report Date
May 12, 2026
EPS Beat/Miss
-109.0%
Price Before
$1.04
Price After
$1.03
Q1 FY2026+0.78%
Report Date
Mar 10, 2026
EPS Beat/Miss
+3.9%
Price Before
$1.29
Price After
$1.30
Q4 FY2025-3.96%
Report Date
Nov 12, 2025
EPS Beat/Miss
+103.3%
Price Before
$2.78
Price After
$2.67
Q3 FY2025+2.55%
Report Date
Aug 14, 2025
EPS Beat/Miss
-222.7%
Price Before
$5.50
Price After
$5.64
Q2 FY2025+0.91%
Report Date
May 13, 2025
EPS Beat/Miss
-53.3%
Price Before
$41.58
Price After
$41.96
Q1 FY2025-3.97%
Report Date
Mar 11, 2025
EPS Beat/Miss
-51.2%
Price Before
$52.92
Price After
$50.82
Q4 FY2024+13.26%
Report Date
Nov 11, 2024
EPS Beat/Miss
+235.9%
Price Before
$76.02
Price After
$86.10
Q3 FY2024-19.25%
Report Date
Aug 13, 2024
EPS Beat/Miss
-98.6%
Price Before
$111.30
Price After
$89.88
Avg Beat Reaction+3.36%
Avg Miss Reaction-4.14%
Beat Rate3 / 8 quarters
Largest Move-19.25% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NUWE ends December
Nuwellis, Inc. (NUWE) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-2.09 — missing the analyst consensus of $-1.00 by -109.0%. The next NUWE earnings date is expected around September 1, 2026.
Each quarter, investors track NUWE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NUWE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NUWE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NUWE earnings · 5 questionsNuwellis, Inc.'s next earnings report is expected around September 1, 2026. NUWE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NUWE historically reports after market close (AMC).
NUWE earnings datewhen is NUWE earningsNUWE next earnings datewhen does NUWE report earningsNUWE earnings calendar
▸ Source: FMP · Nuwellis, Inc. SEC filings · US GAAP · Nuwellis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026